Trade 3SBio Inc. - 1530 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.021644% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000274% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 10 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.25 |
| Open | 6.25 |
| 1-Year Change | 6.84% |
| Day's Range | 6.2 - 6.3 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 22, 2025 | 6.30 | 0.05 | 0.80% | 6.25 | 6.30 | 6.20 |
| Jan 21, 2025 | 6.25 | -0.05 | -0.79% | 6.30 | 6.40 | 6.25 |
| Jan 20, 2025 | 6.30 | 0.15 | 2.44% | 6.15 | 6.45 | 6.15 |
| Jan 17, 2025 | 6.10 | 0.15 | 2.52% | 5.95 | 6.25 | 5.85 |
| Jan 16, 2025 | 5.90 | 0.20 | 3.51% | 5.70 | 5.95 | 5.70 |
| Jan 15, 2025 | 5.70 | 0.00 | 0.00% | 5.70 | 5.75 | 5.65 |
| Jan 14, 2025 | 5.70 | 0.10 | 1.79% | 5.60 | 5.75 | 5.60 |
| Jan 13, 2025 | 5.65 | 0.00 | 0.00% | 5.65 | 5.70 | 5.55 |
| Jan 10, 2025 | 5.65 | -0.05 | -0.88% | 5.70 | 5.75 | 5.60 |
| Jan 9, 2025 | 5.70 | -0.05 | -0.87% | 5.75 | 5.75 | 5.65 |
| Jan 8, 2025 | 5.75 | -0.05 | -0.86% | 5.80 | 5.80 | 5.65 |
| Jan 7, 2025 | 5.80 | 0.00 | 0.00% | 5.80 | 5.85 | 5.75 |
| Jan 6, 2025 | 5.85 | -0.05 | -0.85% | 5.90 | 5.90 | 5.80 |
| Jan 3, 2025 | 5.85 | -0.10 | -1.68% | 5.95 | 5.95 | 5.85 |
| Jan 2, 2025 | 5.90 | -0.15 | -2.48% | 6.05 | 6.05 | 5.90 |
| Dec 31, 2024 | 6.05 | 0.00 | 0.00% | 6.05 | 6.10 | 6.00 |
| Dec 30, 2024 | 6.05 | 0.15 | 2.54% | 5.90 | 6.05 | 5.90 |
| Dec 27, 2024 | 5.85 | -0.10 | -1.68% | 5.95 | 6.00 | 5.85 |
| Dec 24, 2024 | 5.95 | 0.00 | 0.00% | 5.95 | 6.10 | 5.95 |
| Dec 23, 2024 | 6.00 | 0.00 | 0.00% | 6.00 | 6.10 | 5.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
3SBio Company profile
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.| Industry: | Biopharmaceuticals |
瀋陽經濟技術開發區十號路1甲3號
SHENYANG
LIAONING
CN
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com